Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Cipla
Federal Trade Commission
Cerilliant
Mallinckrodt
Dow
Citi
Farmers Insurance
AstraZeneca
Merck

Generated: January 23, 2018

DrugPatentWatch Database Preview

OXSORALEN-ULTRA Drug Profile

« Back to Dashboard

Which patents cover Oxsoralen-ultra, and what generic alternatives are available?

Oxsoralen-ultra is a drug marketed by Dow Pharm and is included in one NDA.

The generic ingredient in OXSORALEN-ULTRA is methoxsalen. There are seven drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the methoxsalen profile page.
Drug patent expirations by year for OXSORALEN-ULTRA
Pharmacology for OXSORALEN-ULTRA
Ingredient-typePsoralens
Drug ClassPhotoactivated Radical Generator
Psoralen
Mechanism of ActionPhotoabsorption
Physiological EffectPhotosensitizing Activity
Medical Subject Heading (MeSH) Categories for OXSORALEN-ULTRA

US Patents and Regulatory Information for OXSORALEN-ULTRA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dow Pharm OXSORALEN-ULTRA methoxsalen CAPSULE;ORAL 019600-001 Oct 30, 1986 AB RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

UBS
Citi
Novartis
Johnson and Johnson
Moodys
Covington
Farmers Insurance
Healthtrust
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot